|
2025 Conference Publication Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type IIAlmass, Adrian, Paterson, Brett, Humphries, James, Grieve, Melyssa, Stimson, Damion, Migotto, Mary-anne, Cowin, Gary and Reutens, David (2025). Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109196 |
|
2024 Conference Publication 64CU-SARTATE™ PET/CT imaging of canine osteosarcomaAlmass, Adrian, Atcheson, Nicole, Paterson, Brett, Lenzo, Nat, Van Dam, Ellen, Lim, Ting Xiang, Harris, Matt, Straw, Rodney, Daniel, Sarah, Stimson, Damion, Reutens, David, Al-najir, Airman and Cathie, Julia (2024). 64CU-SARTATE™ PET/CT imaging of canine osteosarcoma. Australian and New Zealand Society of Nuclear Medicine (ANZSNM) 54th ASM, Christchurch, New Zealand, 26 -28 April 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16442 |
|
2023 Conference Publication Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracersLim, Ting Xiang, Migotto, Mary-Anne, Mardon, Karine, Paterson, Brett and Reutens, David (2023). Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracers. International Symposium on Radiopharmaceutical Sciences iSRS 2023, Honolulu, HI, United States, 22-26 May 2023. Philadelphia, PA, United States: Elsevier. |
|
2023 Conference Publication Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracersLim, Ting Xiang, Migotto, Mary-anne, Mardon, Karine, Paterson, Brett and Reutens, David (2023). Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracers. International Symposium on Radiopharmaceutical Sciences iSRS 2023, Honolulu, HI USA, 22-26 May 2023. Philadelphia, PA USA: Elsevier. doi: 10.1016/j.nucmedbio.2023.108619 |
|
2016 Conference Publication First-Time-in-Human Trial of Cu-64 MeCOSAR-octreotate (CuSARTATE) for Imaging and Dosimetry Estimation in Neuroendocrine Tumor (NET)Hicks, Rodney, Jackson, Price, Ware, Robert, Drummond, Elizabeth, Roselt, Peter, Noonan, Wayne, Price, Roger, Jeffrey, Charmaine, Callahan, Jason, Hong, Emily, Hicks, Lauren, Hedt, Amos, Paterson, Brett, Kong, Grace and Donnelly, Paul (2016). First-Time-in-Human Trial of Cu-64 MeCOSAR-octreotate (CuSARTATE) for Imaging and Dosimetry Estimation in Neuroendocrine Tumor (NET). RESTON: SOC NUCLEAR MEDICINE INC. |
